Soojung Yoo
Psychiatric/Mental Health · Los Angeles, CANPI 1295406502
Payments from drug & device makers
Across 66 payments — averaging $31.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$437
- Alkermes, Inc.$238
- Johnson & Johnson$198
- GSK$185
- Novo Nordisk$160
- Lilly USA, LLC$133
- plus $738 from 17 others
What the payments were for
- Food & beverage$2,088100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 8 | $437 |
| Alkermes, Inc. | 7 | $238 |
| Johnson & Johnson | 6 | $198 |
| GSK | 4 | $185 |
| Novo Nordisk | 3 | $160 |
| Lilly USA, LLC | 5 | $133 |
| AbbVie | 6 | $116 |
| Otsuka America Pharmaceutical, Inc. | 3 | $77 |
| Nestle Healthcare Nutrition Inc. | 3 | $69 |
| Boehringer Ingelheim | 3 | $61 |
| Ironwood Pharmaceuticals, Inc | 3 | $56 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $52 |
| Bayer | 2 | $40 |
| UCB, Inc. | 1 | $38 |
| Vivus LLC | 2 | $37 |
| E.r. Squibb & Sons, L.L.C. | 1 | $30 |
| Abiomed | 1 | $29 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
| Neurocrine Biosciences, Inc. | 1 | $25 |
| Almatica Pharma LLC | 1 | $24 |
| Amgen | 1 | $24 |
| Sunovion Pharmaceuticals Inc. | 1 | $19 |
| Pfizer | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UZEDY$238
- Wegovy$121
- AREXVY$120
- Austedo XR$119
How this compares
$2,088 in reported general payments places this provider in the 80th percentile of 2,433 psychiatric/mental health providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 35 | $31,248 |
| ZenpepLipase/Protease/Amylase | 16 | $23,032 |
| TrulicityDulaglutide | 23 | $21,966 |
| VascepaIcosapent Ethyl | 57 | $20,702 |
| CreonLipase/Protease/Amylase | 15 | $15,660 |
| KerendiaFinerenone | 21 | $14,791 |
| JanuviaSitagliptin Phosphate | 18 | $12,328 |
| LinzessLinaclotide | 12 | $6,296 |
| EliquisApixaban | 11 | $6,112 |
| Memantine Hcl ErMemantine Hcl | 27 | $5,748 |
| Icosapent Ethyl | 21 | $4,633 |
| Dexlansoprazole DrDexlansoprazole | 18 | $3,595 |
| Lidocaine | 27 | $3,299 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 12 | $3,235 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 18 | $1,725 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $61 | $31,24835 claims |
| Lilly USA, LLCTrulicity | $133 | $21,96623 claims |
| AbbVieCreon, Linzess | $116 | $21,95627 claims |
| BayerKerendia | $40 | $14,79121 claims |
| PfizerEliquis | $15 | $6,11211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,433 psychiatric/mental health providers in California.
Other psychiatric/mental health in Los Angeles
- Jovita Ezirim-SalamialofojeLos Angeles$162K
- Sarah KoLos Angeles$34K
- Prince OkosunLos Angeles$12K
- Carey MartinMillbrae$745K
- Liberty MaciasRedlands$288K
- Joshua BurgettSacramento$239K
- Angie-Kolleen TanThousand Oaks$159K
- Thy LamVista$121K
- David OhIrvine$72K
- Samantha PerkinsAnaheim$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.